CN207721969U - A kind of therapeutic device of ophthalmology targeting implantation holder - Google Patents
A kind of therapeutic device of ophthalmology targeting implantation holder Download PDFInfo
- Publication number
- CN207721969U CN207721969U CN201720772956.2U CN201720772956U CN207721969U CN 207721969 U CN207721969 U CN 207721969U CN 201720772956 U CN201720772956 U CN 201720772956U CN 207721969 U CN207721969 U CN 207721969U
- Authority
- CN
- China
- Prior art keywords
- conduit
- holder
- targeting
- optical fiber
- ophthalmology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002513 implantation Methods 0.000 title claims abstract description 21
- 230000008685 targeting Effects 0.000 title claims abstract description 17
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 16
- 239000013307 optical fiber Substances 0.000 claims abstract description 44
- 238000002347 injection Methods 0.000 claims abstract description 16
- 239000007924 injection Substances 0.000 claims abstract description 16
- 230000010412 perfusion Effects 0.000 claims abstract description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 8
- 239000002872 contrast media Substances 0.000 abstract description 2
- 239000007943 implant Substances 0.000 abstract description 2
- 230000003760 hair shine Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000002966 stenotic effect Effects 0.000 abstract 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 229940020947 fluorescein sodium Drugs 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 208000020564 Eye injury Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960002143 fluorescein Drugs 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Radiation-Therapy Devices (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A kind of therapeutic device of ophthalmology targeting implantation holder of the utility model, the optical fiber are set to catheter interior；Optical fibre channel is connected on optical fiber interface；The connector connects injection device, and the optical fibre channel is converted into an access with perfusion access in connector；Injection device can be applied contrast agent in Lai Mushi pipes by conduit injection, can obtain applying the sharp image of Lai Mushi pipes by photograph, preferably to judge the elaborate position at stenotic lesion position.In being implanted into stent procedures, optical fiber head end shines can indicate the position of conduit and holder entrance in real time.Conduit is marked with scale, the distance of instruction push in real time.Holder not only accurately can be pushed into target location by the therapeutic device of the ophthalmology targeting implantation holder of the utility model, easy to operate, and can carry out targeting positioning, find diseased region, the i.e. target location of stenter to implant accurately.
Description
【Technical field】
The utility model is related to a kind of Ophthalmoligic instrument, more particularly to a kind of therapeutic device of ophthalmology targeting implantation holder.
【Background technology】
Glaucoma is the first blinding eye disease of irreversibility in the world, is clinically uniquely effectively controlled through evidence-based medicine EBM confirmation
Treatment method is exactly effective control intraocular pressure.In recent years, research and clinic show that the operation of Schlemm pipe holders can effectively reduce eye
Pressure, compared with traditional modus operandi, no matter the probability of happening of Short-term Complications or long term complication all substantially reduces, operation
Success rate is also promoted.It performs the operation, how accurately and effectively to send holder to Schlemm pipe targets for Schlemm pipe holders
There is direct influence in position to the effect of operation.
Fluorescein angiographic is a kind of emerging eye examination means, using fluorescein sodium as shadow agent processed farmland forearm vein
It is rapidly injected, when fluorescein sodium enters optical fundus blood vessel with blood flow, by the Fundus photography machine of one group of colour filter, persistently shoots eye
The fluorescence form that excitation line is launched is received outside the blood vessel of bottom when dyestuff samsara, to be able to know from experience the fine structure of optical fundus blood vessel
With the variation of micro- samsara, be the pathogenesis of many retinopathies, diagnosis, treatment and prognosis evaluation supply according to.But the technology
There is presently no applied in Schlemm pipes.So fluoroscopic visualization technology is combined with the operation of Schlemm pipe holders, it will
It solves the problems, such as accurately estimate stent implantation site at present, higher success rate of operation and preferably treatment effect will be brought
Fruit.
【Utility model content】
The main purpose of the utility model is to provide a kind of ophthalmology target implantation holder therapeutic device, including conduit,
Injection device, laser generator, optical fiber, ejector sleeve, the conduit have two paths；Described two accesses are optical fibre channel and filling
Note access；Conduit between the laser emitter and connector is optical fibre channel；The optical fiber is set to inside optical fibre channel；
Optical fibre channel is connected on optical fiber interface；The optical fiber connects laser generator by optical fiber interface；The connector is by leading
Pipe connects injection device；Conduit between connector and injection device is perfusion access；The optical fibre channel exists with perfusion access
Connector is converted into an access；One access rear end is connected with connector；The optical fiber extends to one by connector
A access front end；The external catheter end is equipped with holder；The holder is set to ejector sleeve front end.
Further, ejector sleeve is flexible ejector sleeve, internal diameter 0.1-0.25mm, outer diameter 0.2-0.35mm, length 1mm-40mm.
Further, the internal diameter 0.1-0.25mm of the holder, outer diameter 0.2-0.35mm, length 1mm-40mm.
Further, which is made selected from following material, including：Biocompatibility high polymer, stainless steel, gold, silver,
Platinum, nickel etc..
Further, conduit is flexible conduit, outer diameter 0.1-0.25mm, length 20-200mm.
Further, conduit is marked with scale.
Compared with prior art, the utility model has the advantages that：Provide a kind of ophthalmology targeting implantation holder
Therapeutic device, which can carry out targeting positioning, find the elaborate position of diseased region, then by stenter to implant,
Reach better therapeutic effect；The apparatus structure is uncomplicated easy to process, and the presence of optical fiber can be real in implantation process
When indicate the position of holder, bring great convenience to operation and to push process simple, be conducive to promote.
【Description of the drawings】
Fig. 1 is the structural schematic diagram of the therapeutic device of the utility model ophthalmology targeting implantation holder.
【Specific implementation mode】
To make the technical means, creative features, achievement of purpose, and effectiveness of the utility model be easy to understand, below
In conjunction with specific implementation mode, the utility model is expanded on further.
In figure：1- laser generators, 2- optical fiber, 3- conduits, 4- ejector sleeves, 5- holders, 6- connectors, 7- injection devices.
Embodiment:
As shown in Figure 1, a kind of therapeutic device of ophthalmology targeting implantation holder, including conduit 3, injection device 7, laser occur
Device 1, optical fiber 2, ejector sleeve 4, the conduit 3 have two paths；Described two accesses are optical fibre channel and perfusion access；It is described to swash
Conduit 3 between optical transmitting set 1 and connector 6 is optical fibre channel；The optical fiber 2 is set to inside optical fibre channel；Optical fibre channel
It is connected on optical fiber interface；The optical fiber 2 connects laser generator 1 by optical fiber interface；The connector 6 is connected by conduit 3
Connect injection device 7；Conduit 3 between connector 6 and injection device 7 is perfusion access；2 access of the optical fiber exists with perfusion access
Connector 6 is converted into an access；One access rear end connects with connector 6；The optical fiber 2 is extended to by connector 6
One access front end；3 outer end of the conduit is equipped with holder 5；The holder 5 is set to 4 front end of ejector sleeve.
Injection device 7 applies contrast agent fluorescein sodium in Lai Mushi pipes by conduit injection, can be obtained by photograph narrow
The accurate location of narrow diseased region finds the target location of the implantation of holder 5.Optical fiber, which is placed in optical fibre channel, connects laser
Device 1.The light sent out by 2 head end of optical fiber during pushing holder 5 can observe the position of conduit 3 and holder 5 in real time,
It is provided a great convenience to operation.In the present embodiment, the fibre diameter used is 660nm using wavelength for 0.125mm
Red visible is sent out by low-power laser, and the light of this wavelength is to eye injury very little.
It is marked with graduation mark in conduit, can indicate push distance.3 outer end of conduit is provided with ejector sleeve 4 and holder 5.It pushes away
Pipe 4 and holder 5 can be front and back free to slide on conduit 3.The diameter of ejector sleeve is consistent with rack diameter sizes or is slightly larger than holder
Diameter.In stent implantation procedure, holder 5 is pushed into target location by ejector sleeve 4.
The process of targeting implantation holder is as follows：3 end of conduit is stretched into and is applied in Lai Mushi pipes, by injection device 7 to applying
Then injected fluorescein sodium in Lai Mushi pipes passes through the target location for observing and obtaining holder 5 and should being implanted into of taking a picture.Next, will lead
Pipe 3, which continues implantation, to be applied in Lai Mushi pipes, and related holder 5 and ejector sleeve 4 thereon constantly enters together, reaches near target location
Afterwards, the entrance for stopping conduit 3, is pushed into target location, the light that optical fiber 2 is sent out in the process can be indicated with ejector sleeve 4 by holder 5
The graduation mark of the position of holder 5, conduit 3 can push distance with real time inspection.When holder 5 reaches target location, ejector sleeve 4 is connected
It is withdrawn from together with conduit 3.
Wherein, ejector sleeve 4 is flexible ejector sleeve, internal diameter 0.1-0.25mm, outer diameter 0.2-0.35mm, length 1mm-40mm.
Wherein, the internal diameter 0.1-0.25mm of the holder 5, outer diameter 0.2-0.35mm, length 1mm-40mm.
Wherein, which is made selected from following material, including：Biocompatibility high polymer, stainless steel, gold, silver, platinum, nickel
Deng.
Wherein, conduit 3 is flexible conduit, outer diameter 0.1-0.25mm, length 20-200mm.
Wherein, conduit is marked with scale.
The advantages of basic principles and main features and the utility model of the utility model have been shown and described above.One's own profession
The technical staff of industry is it should be appreciated that the present utility model is not limited to the above embodiments, described in above embodiments and description
Only illustrate the principles of the present invention, on the premise of not departing from the spirit and scope of the utility model, the utility model is also
It will have various changes and improvements, these various changes and improvements fall within the scope of the claimed invention.The utility model
Claimed range is defined by the appending claims and its equivalent thereof.
Claims (6)
1. a kind of therapeutic device of ophthalmology targeting implantation holder, including conduit, injection device, laser generator, optical fiber, ejector sleeve,
It is characterized in that：The conduit has two paths；Described two accesses are optical fibre channel and perfusion access；The Laser emission
Conduit between device and connector is optical fibre channel；The optical fiber is set to inside optical fibre channel；Optical fibre channel is connected to optical fiber
On interface；The optical fiber connects laser generator by optical fiber interface；The connector connects injection device by conduit；Connection
Conduit between device and injection device is perfusion access；The optical fibre channel is converted into one in connector with perfusion access and leads to
Road；One access rear end is connected with connector；The optical fiber extends to an access front end by connector；The conduit
Outer end is equipped with holder；The holder is set to ejector sleeve front end.
2. a kind of therapeutic device of ophthalmology targeting implantation holder according to claim 1, it is characterised in that：The ejector sleeve is
Flexible ejector sleeve, internal diameter 0.1-0.25mm, outer diameter 0.2-0.35mm, length 1mm-40mm.
3. a kind of therapeutic device of ophthalmology targeting implantation holder according to claim 1, it is characterised in that：The holder
Internal diameter 0.1-0.25mm, outer diameter 0.2-0.35mm, length 1mm-40mm.
4. a kind of therapeutic device of ophthalmology targeting implantation holder according to claim 1, it is characterised in that：The holder choosing
It is made from following material, including：Biocompatibility high polymer, stainless steel, gold, silver, platinum, nickel etc..
5. a kind of therapeutic device of ophthalmology targeting implantation holder according to claim 1, it is characterised in that：Conduit is flexibility
Conduit, outer diameter 0.1-0.25mm, length 20-200mm.
6. a kind of therapeutic device of ophthalmology targeting implantation holder according to claim 1, it is characterised in that：Conduit is marked with
Scale.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720772956.2U CN207721969U (en) | 2017-06-29 | 2017-06-29 | A kind of therapeutic device of ophthalmology targeting implantation holder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720772956.2U CN207721969U (en) | 2017-06-29 | 2017-06-29 | A kind of therapeutic device of ophthalmology targeting implantation holder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN207721969U true CN207721969U (en) | 2018-08-14 |
Family
ID=63090209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201720772956.2U Active CN207721969U (en) | 2017-06-29 | 2017-06-29 | A kind of therapeutic device of ophthalmology targeting implantation holder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN207721969U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107174397A (en) * | 2017-06-29 | 2017-09-19 | 天津优视眼科技术有限公司 | A kind of therapeutic system of ophthalmology targeting implantation support |
| CN111803273A (en) * | 2020-08-20 | 2020-10-23 | 宋一帆 | Schlemm's tube expansion stent and expansion method |
-
2017
- 2017-06-29 CN CN201720772956.2U patent/CN207721969U/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107174397A (en) * | 2017-06-29 | 2017-09-19 | 天津优视眼科技术有限公司 | A kind of therapeutic system of ophthalmology targeting implantation support |
| CN111803273A (en) * | 2020-08-20 | 2020-10-23 | 宋一帆 | Schlemm's tube expansion stent and expansion method |
| CN111803273B (en) * | 2020-08-20 | 2024-09-13 | 北京大学第三医院（北京大学第三临床医学院） | Schlemm's tube expansion bracket and expansion method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106659868B (en) | Sample of tissue and cancer treatment facilities | |
| KR100855740B1 (en) | Treatment of ocular disease | |
| CN101052434A (en) | Apparatus and method for ocular treatment | |
| CN207721969U (en) | A kind of therapeutic device of ophthalmology targeting implantation holder | |
| CN106618803A (en) | Artificial heart valve prosthesis conveying device | |
| CN108245740A (en) | Optical fiber is injected and suction unit | |
| CN210077799U (en) | Urethral suction device for urethral calculus in urology surgery | |
| CN206304214U (en) | Foley's tube | |
| RU85086U1 (en) | INTUBATION KIT FOR BICANALICULAR DRAINING OF TRAUMATIC WAYS | |
| CN107174397A (en) | A kind of therapeutic system of ophthalmology targeting implantation support | |
| CN109381246B (en) | Multi-functional intelligent medical device that punctures | |
| CN103976763B (en) | Tissue morcellating mirror and operating method thereof | |
| CN208388683U (en) | A kind of blood vessel proximal end protector | |
| CN201076498Y (en) | Optical fiber sucker for intracranial hematoma | |
| CN106691679A (en) | Pushing device of Schlemm's canal bracket | |
| CN210170139U (en) | Visual sheath for puncture | |
| CN204307191U (en) | A kind of mammary ductography pin | |
| CN209437206U (en) | A kind of fiberoptic ductoscopy with inspection positioning device | |
| CN208096870U (en) | A kind of driving means for applying Lai Mushi pipe holder | |
| CN208693250U (en) | A kind of ophthalmology high speed, high resolution multifunctional optical coherence tomography device based on slit-lamp platform | |
| CN204581449U (en) | The diacan of improvement | |
| CN205434673U (en) | Gynaecology's cervical dyeing is with sponge stick | |
| CN205198608U (en) | Scope injection device with adjustable | |
| CN101889854A (en) | Visual interstitial catheter type surgical instrument | |
| CN215384469U (en) | Milk tube support |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231208 Address after: 300300 Tianjin Binhai New Area Tianjin Pilot Free Trade Zone (Airport Economic Zone) West 8th Road No. 9 Factory Building 1 Third Floor West Zone Patentee after: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Patentee after: BEIJING TIANMING OPHTHALMIC NEW TECHNOLOGY DEVELOPMENT CO. Address before: 300203 Tianjin Binhai New Area pilot free trade zone (Airport Economic Zone) Patentee before: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Patentee before: BEIJING TONGREN HOSPITAL, CAPITAL MEDICAL University |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240319 Address after: 300000 Tianjin Binhai New Area Free Trade Pilot Zone (Airport Economic Zone) West 8th Road, Building 9, West 3rd Floor, West Zone Patentee after: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Country or region after: Zhong Guo Address before: 300300 Tianjin Binhai New Area Tianjin Pilot Free Trade Zone (Airport Economic Zone) West 8th Road No. 9 Factory Building 1 Third Floor West Zone Patentee before: TIANJIN YOUSHI OPHTHALMIC TECHNOLOGY CO.,LTD. Country or region before: Zhong Guo Patentee before: BEIJING TIANMING OPHTHALMIC NEW TECHNOLOGY DEVELOPMENT CO. |
|
| TR01 | Transfer of patent right |